Micro Developing Active

Novo Nordisk lancia Wegovy a dose più alta

Punteggio

0,5

Velocità

▲ 0,0

Articoli

Fonti

Riepilogo

Un articolo appartiene a questa narrazione se discute del lancio da parte di Novo Nordisk di una versione a dosaggio più elevato del suo farmaco per la perdita di peso Wegovy.

Fonti

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in … CNBC

Could This New Approval Be a Turning Point For Novo … Nasdaq

Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In … Nasdaq

Novo Nordisk shares rise after Wegovy recommended by Britain's drug … CNBC

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as … CNBC

India is launching cheap, weight-loss drugs and Novo Nordisk is … CNBC

This Hims & Hers Move Could Destroy Competitors Nasdaq

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too … Nasdaq

Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and … Yahoo Finance

Cronologia

Ultimo aggiornamento Mar 19, 2026

Novo Nordisk lancia Wegovy a dose più alta

Riepilogo

Articoli Correlati

Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England

Could This New Approval Be a Turning Point For Novo Nordisk?

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to …

This Hims & Hers Move Could Destroy Competitors

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and other weight-loss drugs.

Fonti

Cronologia